Clinical Trial Update: Tranexamic Acid in Adherent Placenta (TAP) [Phase 3]

View source ↗

Summary

Phase 3 trial of tranexamic acid in adherent placenta was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Placenta Accreta

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Placenta Accreta | Phase 3 | Status: WITHDRAWN